The challenges of clinical trials for adolescents and young adults with cancer
Open accessThe DOI matches its Crossref record.
Abstract
In the United States, Europe, and Australia, and probably all countries of the world, older adolescents and young adults with cancer are under-represented in clinical trials of therapies that could improve their outcome. Simultaneously, the survival and mortality rates in these patients have mirrored the clinical trial accrual pattern, with little improvement compared with younger and older patients. This suggests that the relative lack of participation of adolescent and young adult patients in clinical trials has lessened their chances for as good an outcome as that enjoyed by patients in other age groups. Thus, increased availability of and participation in clinical trials is of paramount important if the current deficits in outcome in young adults and older adolescents are to be eliminated. Regardless of whether there is a causal relationship, the impact of low clinical trial activity on furthering our scientific knowledge and management of cancer during adolescence and early adulthood is detrimental.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 18
- Peppercorn, 2004, Lancet, 363, 263, 10.1016/S0140-6736(03)15383-4 · DOI · Paper page
- Kumar, 2005, BMJ, 331, 1295, 10.1136/bmj.38628.561123.7C · DOI · Paper page
- Meadows, 1983, Cancer Invest, 1, 149, 10.3109/07357908309040932 · DOI
- Wagner, 1995, Med Pediatr Oncol, 24, 281, 10.1002/mpo.2950240503 · DOI
- Lennox, 1979, BMJ, 2, 567, 10.1136/bmj.2.6190.567 · DOI
- Duffner, 1982, Cancer, 50, 1636, 10.1002/1097-0142(19821015)50:8<1636::AID-CNCR2820500829>3.0.CO;2-6 · doi:10.1002/1097-0142(19821015)50:8<1636::aid-cncr2820500829>3.0.co;2-6
- Nachman, 1993, Cancer, 71, 3377, 10.1002/1097-0142(19930515)71:10+<3377::AID-CNCR2820711741>3.0.CO;2-8 · doi:10.1002/1097-0142(19930515)71:10+<3377::aid-cncr2820711741>3.0.co;2-8
- Stock, 2000, Blood, 96, 467a
- Boissel, 2003, J Clin Oncol, 21, 774, 10.1200/JCO.2003.02.053 · DOI · Paper page
- de Bont, 2004, Leukemia, 18, 2032, 10.1038/sj.leu.2403538 · DOI · Paper page
- Schroeder, 2005, Pediatr Blood Cancer, 45, 578a
- Ramanujachar, 2006, Pediatr Blood Cancer, 47, 748, 10.1002/pbc.20776 · DOI
- Ramanujachar, 2006, Pediatr Blood Cancer, 48, 254, 10.1002/pbc.20749 · DOI · Paper page
- Testi, 2006, J Clin Oncol, 24, 508s, 10.1200/jco.2006.24.18_suppl.9024 · DOI
- Paulussen, 2003, Proc Amer Soc Clin Oncol, 22, 816a
- Ferrari, 2003, Cancer, 98, 571, 10.1002/cncr.11550 · DOI · Paper page
- , . Older adolescents and young adults with cancer and clinical trials: Lack of participation and progress in North America. In: , editors. Cancer in adolescents and young adults. Heidelburg: Springer Verlag; 2007. pp. 71–81. · doi:10.1007/978-3-540-68152-6_5
- Bleyer, 2006, Cancer, 107, 1645, 10.1002/cncr.22102 · DOI · Paper page
Cited by
Declining childhood and adolescent cancer mortality
Smith, M. A., Altekruse, S. F., Adamson, P. C., Reaman, G. H., & Seibel, N. L. (2014) · Cancer · doi:10.1002/cncr.28748 · Cited by 542
“There have been concerns that the improvements in outcome observed for many childhood cancers have not been observed for adolescents or young adults with cancer.(13) The results we report here indicate that, from 2000 to 2010,”
Barr, R. D., Ferrari, A., Ries, L., Whelan, J., & Bleyer, W. A. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.4689 · Cited by 451
Self-citationSadovsky, R., Basson, R., Krychman, M., Morales, A. M., Schover, L., Wang, R., & Incrocci, L. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01620.x · Cited by 310
Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Coccia, P. F., Pappo, A. S., Beaupin, L., Borges, V. F., Borinstein, S. C., Chugh, R., Dinner, S., Folbrecht, J., Frazier, A. L., Goldsby, R., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0001 · Cited by 295
Cancer in Young Adults 20 to 39 Years of Age: Overview
Bleyer, A., & Barr, R. (2009) · Seminars in Oncology · doi:10.1053/j.seminoncol.2009.03.003 · Cited by 144
Self-citationAristizabal, P., Singer, J., Cooper, R., Wells, K. J., Nodora, J., Milburn, M., Gahagan, S., Schiff, D. E., & Martinez, M. E. (2015) · Pediatric Blood & Cancer · doi:10.1002/pbc.25472 · Cited by 106
Freyer, D. R., & Seibel, N. L. (2015) · Current Pediatrics Reports · doi:10.1007/s40124-015-0075-y · Cited by 65
Rosenberg, A. R., Bona, K., Wharton, C. M., Bradford, M., Shaffer, M. L., Wolfe, J., & Baker, K. S. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.25843 · Cited by 36
“Improving health and psychosocial outcomes for Adolescents and Young Adults (AYAs) with cancer has been difficult because their participation in clinical and patient-reported outcomes (PROs) research has been lacking.[1,2] For example, despite extensive efforts (e.”
BackgroundBleyer, W. A. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181ff6509 · Cited by 33
Lester, E., DiStefano, S., Mace, R., Macklin, E., Plotkin, S., & Vranceanu, A.-M. (2020) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2019.12.001 · Cited by 22
Metadata
- Authors
- Ferrari, A., Montello, M., Budd, T., & Bleyer, A.
- Venue
- Pediatric Blood & Cancer
- Publisher
- Wiley
- Published
- 2008
- Volume
- 50
- Issue
- S5
- Pages
- 1101-1104
- ISSN
- 1545-5009 (ISSN-L)
- 1545-5017
- OpenAlex
- W2092736117
- Cited by
- 131
- References
- 0
- FWCI
- 9.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 2800 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.